Common Equity: The sum of all common equity items.
Novo Nordisk A/S (NVO) had Common Equity of $20.81B for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$42.11B |
|
$14.64B |
|
$6.46B |
|
$35.65B |
|
$23.50B |
|
$18.61B |
|
$-166.46M |
|
$18.44B |
|
$18.44B |
|
$14.64B |
|
$14.64B |
|
$14.64B |
|
$14.64B |
|
$18.61B |
|
$21.38B |
|
4.45B |
|
4.46B |
|
$3.29 |
|
$3.28 |
|
| Balance Sheet Financials | |
$23.33B |
|
$23.56B |
|
$44.21B |
|
$67.54B |
|
$31.54B |
|
$13.00B |
|
$15.19B |
|
$46.73B |
|
|
Common Equity |
$20.81B |
$4.70B |
|
$20.81B |
|
4.46B |
|
| Cash Flow Statement Financials | |
$17.54B |
|
$-18.69B |
|
$1.27B |
|
$2.09B |
|
$2.27B |
|
$183.13M |
|
$331.90M |
|
$-6.40B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.74 |
|
-- |
|
-- |
|
0.38 |
|
0.72 |
|
84.67% |
|
44.19% |
|
44.19% |
|
50.77% |
|
43.80% |
|
34.78% |
|
$10.70B |
|
-- |
|
-- |
|
-- |
|
0.62 |
|
1.09 |
|
3.32 |
|
109.87 |
|
70.38% |
|
311.73% |
|
21.68% |
|
43.31% |
|
$4.66 |
|
$2.40 |
|
$3.93 |
|